Vaccine Visionary Peter Marks Exits FDA Amid Controversy

Peter Marks, a key figure in the development of COVID-19 vaccines, has been ousted from the U.S. FDA. Citing a lack of truth and transparency, Marks chose to resign. Plans for restructuring federal health agencies are underway, with potential downsizing and centralization of functions.


Devdiscourse News Desk | Updated: 29-03-2025 07:16 IST | Created: 29-03-2025 07:16 IST
Vaccine Visionary Peter Marks Exits FDA Amid Controversy

The U.S. Food and Drug Administration's leading vaccine expert, Peter Marks, has been ousted, as reported by the Wall Street Journal on Friday.

Having been instrumental in vaccine development during Trump's first term, Marks faced an ultimatum to resign or be dismissed, linked to a lack of the desired transparency by top health officials.

In his resignation letter, Marks lamented the preference for misinformation by authorities. His departure is slated for April 5, amidst wider reforms to reshape public health agencies led by Robert F. Kennedy Jr.

(With inputs from agencies.)

Give Feedback